树突状细胞疫苗在消化道肿瘤中的应用现状
被引量:1
摘要
免疫学治疗恶性肿瘤的研究越来越受到人们的重视,T细胞介导的免疫应答在机体抗肿瘤过程中起着主导作用。树突状细胞(DC)在体内外都能诱导特异性的细胞毒性T淋巴细胞(CTL)生成^[1]。目前DC疫苗在各类癌症方面的应用研究很深入且广泛。现就近年DC疫苗在消化道肿瘤治疗中的应用现状进行综述。
出处
《中国医师进修杂志》
2010年第6期72-73,共2页
Chinese Journal of Postgraduates of Medicine
参考文献17
-
1Steinman RM.The dendritic cell system and its role in immunogenicity.Annu Rey Immunol,1991,9(3):271-296.
-
2Salskov-Iversen M,Berger CL,Edelson RL.Rapid construction of a dendritic cell vaccine through physical perturbation sad apoptotic malignant T cell loading,J Immune Based Ther Vaccines,2005,3(1):4.
-
3Girardi M.Immunosurveillance and immunoregulation by gammadelta T cells.Invest Dermatol,2006,126(1):25-31.
-
4Gabrilovich DI,Chen HL,Girgis KR,et al.Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.Nat Med,1996,2(10):1096-1103.
-
5Chaux P,Moutet M,Faivre J,et al.Inflammatory cells infiltrating human colorectal carcinomas express HLA class Ⅱ but not B7-1 and B7-2 costimulatory molecules of the T-cell activation.Lab Invest,1996,74(5):975-983.
-
6Saito H,Tsujitani S,Ikeguchi M,et al.Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue.Br J Cancer,1998,78(12):1573-1577.
-
7Tsujitani S,Kakeji Y,Watanabe A,et al.Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer.Int Surg,1992,77(4):238-241.
-
8刘思纯,袁世珍.结直肠癌树突状细胞浸润及癌周淋巴细胞反应与预后的关系[J].新消化病学杂志,1997,5(3):156-157. 被引量:11
-
9刘思纯,袁世珍,陈国帧.大肠癌组织树突状细胞与病理特征及预后的关系[J].中山医科大学学报,1996,17(4):260-263. 被引量:9
-
10Furihata M,Ohtsuki Y,Ido E,et al.HLA-DB antigen-and S-100 protein-pesitive dendritic cells in esophageal squamous cell carcinoma--their distribution in relation to prognosis.Virchows Arch B Cell Pathol Incl Mol Pathol,1992,61(6):409-414.
二级参考文献30
-
1高建,陈敏,彭明利,任红.肝癌细胞裂解物致敏的树突状细胞瘤苗体外诱导特异性抗肝癌免疫[J].中华肝脏病杂志,2005,13(3):198-201. 被引量:11
-
2盛立霞,邱国强,谢晓宝,顾伟英,王志林,吴浩清.两种白血病细胞抗原负载DC的体外诱导特异性CTL应答的比较[J].细胞与分子免疫学杂志,2005,21(2):205-209. 被引量:12
-
3Vasir B, Borges V, Wu Z, et al. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation[J]. Br J Haematol , 2005,129 (5) : 687- 700.
-
4Strome SE, Voss S, Wilcox R, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response[J]. Cancer Res, 2002,62 (6) : 1884-1889.
-
5Singh-Jasuja H, Hilf N, Arnold-Schild D, et al. The role of heat shock proteins and their receptors in the activation of the immune system[J]. Biol Chem, 2001,382(4) :629-636.
-
6Srivastava PK, Amato RJ. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infections agents [J]. Vaccine, 2001,19 (17-19) : 2590-2597.
-
7Zheng H,Dai J,Stoilova D,et al. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity[J]. J Immunol,2001,167(12) :6731-6735.
-
8团体著者,中国常见恶性肿瘤诊治规范.第3分册,1990年
-
9Kugler A, Stuhler G, Walden P, et al. Regression of human meta static renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med, 2000, 6: 332-336.
-
10Banchereau J, Palucka AK, Dhodapkar M, et al. Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res, 2001, 61:6451- 6458.
共引文献29
-
1孙献甫,詹友庆.肿瘤浸润树突状细胞在胃癌中的研究进展[J].实用肿瘤杂志,2005,20(3):273-276.
-
2雷晓,余佩武,石彦,唐波,饶芸,吴淼,周立新.胃癌浸润性树突状细胞CD83和S100的表达及其临床意义[J].中国普通外科杂志,2005,14(10):740-743. 被引量:2
-
3雷晓,余佩武,饶芸,唐波,石彦,吴淼,周立新.CD83^+肿瘤浸润性树突状细胞在胃癌组织的表达及临床意义[J].第三军医大学学报,2006,28(5):401-403. 被引量:4
-
4赵晓华,纪新强.宫颈癌组织中树突状细胞和ICAM-1的表达[J].齐鲁医学杂志,2007,22(1):62-64. 被引量:4
-
5李晓锋,杜智.树突状细胞疫苗治疗肝细胞癌的现状[J].实用肝脏病杂志,2008,11(2):129-132.
-
6罗善明,高建,彭明利.sCD40L联合TB.HSP70-H22肽刺激树突状细胞诱导特异性抗肿瘤免疫的研究[J].第三军医大学学报,2009,31(11):1024-1028. 被引量:2
-
7关弘,温文,黄忠华,许美权,昝沁.肿瘤浸润树突状细胞在胃腺癌的分布及P53表达的临床病理意义[J].中外医疗,2009,28(22):26-27. 被引量:2
-
8詹俊,孙小娟,李楚强,于钟.S100和CD83阳性树突状细胞与大肠肿瘤微环境的关系[J].世界华人消化杂志,2009,17(29):3061-3065. 被引量:6
-
9吕国强,许炳华,沈晓明,李丽,项方.进展期胃癌术后树突状细胞疫苗同步化学治疗的免疫功能监测[J].中华消化杂志,2009,29(12):825-828. 被引量:8
-
10傅振坤,李殿俊.肿瘤的自体细胞免疫治疗在国内的应用现状[J].实用肿瘤学杂志,2011,25(1):1-3. 被引量:2
同被引文献35
-
1陈文宽,陈福进,曾宗渊,伍国号,郭朱明,魏茂文,杨安奎,张诠,何洁华,候景辉.CD1a标记树突细胞在声门型喉鳞癌中的表达及其临床意义[J].癌症,2005,24(9):1124-1126. 被引量:3
-
2郭连军,贾立敏,贺业春,刘颖.喉癌组织中血管内皮生长因子、CD1a阳性树突状细胞表达及相关性的研究[J].现代生物医学进展,2007,7(2):196-198. 被引量:5
-
3尤健,陈华,张立华,王长利.CA-9、CD1a、CD3和EGFR在Ⅰ期非小细胞肺癌中的表达及临床意义[J].中国肿瘤临床,2007,34(13):735-739. 被引量:4
-
4Salio M, Silk JD, Cerundolo V. Recent advances in processing and presentation of C D 1 bound lipid antigens [J ]. Curr Opin Immunol, 2010,22( 1 ) :81-88.
-
5de Libero G, Mori L. How the immune system detects lipid antigens [J]. Prog Lipid Res,2010,49(2): 120-127.
-
6Zeng Z, Castao AR, Segelke BW, et al. Crystal structure of mouse C D 1 :an MHC-like fold with a large hydrophobic binding groove[ J ]. Science, 1997, 277(5324) : 339-345.
-
7Coventry B,Heinzel S. CDla in human cancers:a new role for an old molecule [ J ]. Trends Immunol, 2004,25 ( 5 ) : 242-248.
-
8Porcelli SA,Modlin RL.The CD1 system:antigen-presenting molecules for T cell recognition of lipids and glycolipids [ J ]. Annu Rev Immunol, 1999,17 : 297-329.
-
9Swann J,Crowe NY,Hayakawa Y,et al. Regulation of antitumourimmunity by CDld-restricted NKT ceils [J]. Immunol Cell Biol, 2004,82(3) :323-331.
-
10Geissmann F, Manz MG, Jung S, et al. Development of monocytes, macrophages, and dendritic ceils [ J ]. Science, 2010,327 (5966) : 656-661.
二级引证文献3
-
1张洁,徐长福,莫立平,孙颖,韩水平,赵文宝.CD1a、CD209及MHCII在新生儿指皮组织中的表达及意义[J].现代生物医学进展,2016,16(18):3452-3455.
-
2谢云青,陈莉,杨建伟,陈路川,刘施佳,应敏刚,郑秋红.DC-CIK细胞联合常规治疗对肾透明细胞癌患者的临床疗效[J].中国肿瘤生物治疗杂志,2017,24(6):665-669. 被引量:2
-
3夏良绪,林存智,邵明菊,崔世超,曹艺巍,吕志华.仿刺参体壁提取物海参糖胺聚糖对肺结核患者外周血体外细胞免疫调节功能的影响[J].中国医师杂志,2018,20(9):1334-1337. 被引量:3
-
1高亭,蒋引娣,李敏,党焱,何小鹏.非小细胞肺癌的免疫学治疗进展[J].临床肺科杂志,2015,20(10):1893-1896. 被引量:4
-
2曹磊,任华.肺癌的免疫学治疗[J].协和医学杂志,2011,2(1):79-84. 被引量:1
-
3马骥超,柴万兴.中枢神经系统恶性肿瘤的免疫学治疗[J].中华外科杂志,1993,31(1):60-62.
-
4刘煜昊,葛海燕.光动力学在消化道肿瘤治疗及其机理研究的进展[J].应用激光,2007,27(6):527-529. 被引量:1
-
5王旭杰,王松,冯卫华,于春鹏.铂类药物在原发性肝癌介入治疗中的临床研究进展[J].齐鲁医学杂志,2014,29(4):373-374. 被引量:5
-
6罗天航,方国恩.腹腔化疗在消化道肿瘤治疗中的价值[J].世界肿瘤杂志,2005,4(1):49-52. 被引量:4
-
7张鹏程,梁鲁,姚碧辉,宋磊.转录因子Sp1的高表达在消化道肿瘤治疗中的临床意义[J].中华临床医师杂志(电子版),2012,6(17):5227-5229. 被引量:1
-
8刘昌俊.生物制剂在消化道肿瘤治疗中的应用[J].国外医学(肿瘤学分册),1998,25(3):163-165.
-
9韩延风.内镜黏膜下剥离术治疗消化道肿瘤疗效观察[J].现代消化及介入诊疗,2015,20(4):409-410. 被引量:6
-
10刘宝善.TPN在消化道肿瘤治疗中的作用[J].四川肿瘤防治,1996,9(4):49-51. 被引量:5